Showing 7,061 - 7,080 results of 7,634 for search 'Alstom~', query time: 2.16s Refine Results
  1. 7061

    FAM210B activates STAT1/IRF9/IFIT3 axis by upregulating IFN-α/β expression to impede the progression of lung adenocarcinoma by Xuejuan Gao, Donglan Huang, Ying Liu, Gui Zhang, Xiaofen Zheng, Baiye Guan, Aiwen Chen, Jiayao Wu, Shi-Ming Luo, Zonghua Liu, Luxuan Chen, Xiaohui Liu, Jingjie Jin, Xingfeng Yin, Zhenghua Sun, Yunfang Zhang, Meizhi Lu, Gong Zhang, Wanting Liu, Langxia Liu

    Published 2025-02-01
    “…Furthermore, TOM70 (Translocase of outer mitochondrial membrane 70, also named as TOMM70) has been identified as a functional interacting partner of FAM210B in its modulation on the expression of IFN-α/β, as well as the proliferative and metastatic phenotypes of LUAD cells. …”
    Get full text
    Article
  2. 7062

    Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process by Breanne Stewart, Pirkko Lepola, Gunter F. Egger, Fahimeda Ali, Albert J. Allen, Albert J. Allen, Alysha K. Croker, Andrew J. Davidson, Pamela Dicks, Saul N. Faust, Saul N. Faust, Dionna Green, Collin Hovinga, Collin Hovinga, Agnes V. Klein, Robyn Langham, Hidefumi Nakamura, Laura Pioppo, Shiva Ramroop, Michiyo Sakiyama, Isabel Sanchez Vigil de la Villa, Junko Sato, Donna L. Snyder, Mark A. Turner, Mark A. Turner, Sarah Zaidi, Kanecia Zimmerman, Kanecia Zimmerman, Thierry Lacaze-Masmonteil

    Published 2025-02-01
    “…This work, undertaken by the Working Group (WG) on International Collaborations at the European Network of Pediatric Research at the European Medicines Agency (Enpr-EMA) aims to describe the research ethics review requirements including any pediatric specific requirements, as well as current or upcoming changes across six jurisdictions – the European Union (EU), United Kingdom (UK), United States of America (USA), Canada, Japan, and Australia.MethodsAn open questionnaire developed by the WG and directed at both the Competent Authorities (CA) and the national pediatric clinical trial networks arranged by jurisdictions.ResultsA synopsis of the current regulatory requirements covers centralized versus independent review, comparisons between investigator initiated and industry sponsored clinical trials, timelines, review board members requirements and the consenting/assent process for clinical trial (CT) applications, application submission processes and application requirements for each of the six jurisdictions. It also describes changes currently or soon to be implemented in some jurisdictions.ConclusionThis environmental scan highlights the differences in ethics review for CTs in pediatric medicine development across six jurisdictions. …”
    Get full text
    Article
  3. 7063

    Dynamic Challenges of Active Tuberculosis: Prevalence and Risk Factors of Co-Infection in Clinical and Microbiological Characteristics at King Abdulaziz University Hospital, Jeddah... by Mokhtar JA, Attallah DM, Jiman-Fatani AA, Al-Rabia MW, Alqarni MA, Saleh BH, Amboon MM, Altorki TA, Alkuwaity KK, Abujamel T, Kaki R, Albarakati TN, Daghistani H, Ismail MA, Alharbi O, Abu ITM, Alfadil A, Ibrahem K, Mufrrih M, Sait AM

    Published 2025-02-01
    “…The results were presented using beta coefficients (B) to quantify the relationship between predictors and the outcome, along with the adjusted odds ratio (AOR) to provide an interpretable measure of the strength of these associations.Results: Of the 131 TB patients involved in this paper, a higher incidence of pulmonary TB was observed among men under 30 years old. This group also showed a higher mortality rate due to comorbidities such as renal failure, human immunodeficiency virus (HIV), and autoimmune disease. …”
    Get full text
    Article
  4. 7064
  5. 7065

    Adaptive anomaly detection disruption prediction starting from first discharge on tokamak by X.K. Ai, W. Zheng, M. Zhang, Y.H. Ding, D.L. Chen, Z.Y. Chen, B.H. Guo, C.S. Shen, N.C. Wang, Z.J. Yang, Z.P. Chen, Y. Pan, B. Shen, B.J. Xiao, J-TEXT team

    Published 2025-01-01
    “…In this period disruption prediction also aims to support safe exploration of operation range and accumulate necessary data to develop advanced prediction models. …”
    Get full text
    Article
  6. 7066

    The 0ν2β-decay CROSS experiment: preliminary results and prospects by The CROSS collaboration, I. C. Bandac, A. S. Barabash, L. Bergé, M. Brière, C. Bourgeois, P. Carniti, M. Chapellier, M. de Combarieu, I. Dafinei, F. A. Danevich, N. Dosme, D. Doullet, L. Dumoulin, F. Ferri, A. Giuliani, C. Gotti, P. Gras, E. Guerard, A. Ianni, H. Khalife, S. I. Konovalov, E. Legay, P. Loaiza, P. de Marcillac, S. Marnieros, C. A. Marrache-Kikuchi, C. Nones, V. Novati, E. Olivieri, C. Oriol, G. Pessina, D. V. Poda, T. Redon, V. I. Tretyak, V. I. Umatov, M. M. Zarytsky, A. S. Zolotarova

    Published 2020-01-01
    “…Rejection factors higher than 99.9% of α surface radioactivity have been demonstrated in a series of prototypes based on crystals of Li2MoO4 and TeO2. We have also shown that point-like energy depositions can be identified up to a distance of ∼ 1 mm from the coated surface. …”
    Get full text
    Article
  7. 7067

    ABO-incompatible liver transplantation – exploring utilitarian solutions to restricted access and organ shortages: A single-centre experience from Johannesburg, South Africa by E U Wessels, J Loveland, H Maher, P Gaylard, B Bobat, A D Mahomed, D Parbhoo, M R Beretta, C Hajinicolaou, P Walabh, S Berkenfeld, D Demopoulos, S Rambarran, B Ströbele, F van der Schyff, J Fabian, L Brannigan

    Published 2024-04-01
    “…There were significantly increased relative risks of relook surgery for the ABOi group compared with the ABOc group, both overall (relative risk (RR) 1.74; 95% CI 1.10 - 2.75) and at 90 days (RR 2.28; 95% CI 1.27 - 4.11); and also, for pre-discharge bloodstream infection (BSI), (RR 1.84; 95% CI 1.11 - 3.06). …”
    Get full text
    Article
  8. 7068

    Deteksi Persamaan Pola Gerakan pada Koreografi Tari Bali by Ni Made Rai Maryati, Made Windu Antara Kesiman, I Made Gede Sunarya

    Published 2023-10-01
    “…Dances are not only an entertainment but also means of religious ceremonies and tourism assets. …”
    Get full text
    Article
  9. 7069

    Editorial by Ann-Kristin Kölln, Antony Mason, Maria Lenk, Jörg Tremmel, Markus Rutsche

    Published 2018-12-01
    “…Aksel Sundström and Daniel Stockemer, also among the winners of the Intergenerational Justice Prize 2017/18, take a closer look at the age of parliamentarians and investigate which political parties can help to foster the election of young parliamentarians, and to what extent. …”
    Get full text
    Article
  10. 7070

    Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS by Thomas Cluzeau, Fabio Guolo, Edmond Chiche, Paola Minetto, Ramy Rahme, Sarah Bertoli, Luana Fianchi, Jean-Baptiste Micol, Michele Gottardi, Pierre Peterlin, Sara Galimberti, Xavier Thomas, Giuliana Rizzuto, Olivier Legrand, Michela Rondoni, Emmanuel Raffoux, Giambattista Bertani, Alexis Caulier, Michelina D’Argenio, Caroline Bonmati, Atto Billio, Caroline Lejeune, Barbara Scappini, Arnaud Pigneux, Patrizia Zappasodi, Christan Recher, Francesco Grimaldi, Lionel Ades, Roberto M. Lemoli

    Published 2025-02-01
    “…In a multivariate analysis, only MRD >10–3 was associated with a poorer OS (hazard ratio, 2.6; 95% confidence interval, 1.2-5.5; P = .013). We also observed a trend toward a better median OS in patients who underwent hematopoietic stem cell transplantation with MRD <10–3 (not reached vs 26.0 months; P = .06). …”
    Get full text
    Article
  11. 7071

    The efficacy of sodium-glucose transporter 2 inhibitors in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis by Hongsheng Li, Yanli Hou, Wenyong Xin, Lina Ding, Ying Yang, Yikun Zhang, Wenqi Wu, Zhibin Wang, Wenyu Ding

    Published 2025-03-01
    “…SGLT-2 inhibitors intervention was also associated with significant reductions in body weight (MD [95 % CI]; −2.72 kg [-3.49, −1.95], p < 0.00001) and BMI (MD [95 % CI]; −1.11 kg/m2 [-1.39, −0.82], p < 0.00001) and improvements in glycaemic indices, triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C). …”
    Get full text
    Article
  12. 7072

    Editorial by Pieter Vanhuysse, Antony Mason, Jörg Tremmel, Markus Rutsche, Maria Lenk

    Published 2018-01-01
    “…Building on earlier work by Gál et al.,[3] they also show that conclusions on the very direction of intergenerational resource transfers simply reverse when the scope of analysis moves from public policies to the total economy including households. …”
    Get full text
    Article
  13. 7073

    Adverse events in the nervous system associated with blinatumomab: a real-world study by Wen Gao, Jingwei Yu, Yifei Sun, Zheng Song, Xia Liu, Xue Han, Lanfan Li, Lihua Qiu, Shiyong Zhou, Zhengzi Qian, Xianhuo Wang, Huilai Zhang

    Published 2025-02-01
    “…The highest fatality rate for neurological events was observed for increased intracranial pressure disorders, which also had the highest co-occurrence rate with cytokine release syndrome (CRS). …”
    Get full text
    Article
  14. 7074

    Territorios rurales en transformación: desafíos y oportunidades frente al reto de la despoblación by Néstor Vercher

    Published 2025-02-01
    “…Indeed, the crisis in agriculture and livestock farming accelerated the abandonment of farms already during the 60s and 70s of the last century (as can also be seen in the picture), reducing economic opportunities. …”
    Get full text
    Article
  15. 7075
  16. 7076

    Territorios rurales en transformación: desafíos y oportunidades frente al reto de la despoblación by Néstor Vercher

    Published 2025-02-01
    “…Indeed, the crisis in agriculture and livestock farming accelerated the abandonment of farms already during the 60s and 70s of the last century (as can also be seen in the picture), reducing economic opportunities. …”
    Get full text
    Article
  17. 7077

    بررسی اثر پوشش گلس بید و صدف بر روی ویژگی های فیزیکی و مکانیکی نانوکامپوزیت های زمینه پلیمری تقویت شده با الیاف شیشه و آرد چوب راش... by سپیده ساسانیان, آرش فرج پور رودسری, اصغر تابعی

    Published 2024-12-01
    “…آزمون‌های برای سنجش خواص فیزیکی و مکانیکی شامل میزان جذب آب و واکشیدگی ضخامت، خمش، کشش، ضربه و سایش بر روی نمونه‌ها براساس درستورالعمل ASTM با سه تکرار انجام شد، درنهایت با وزن مخصوص سنگ نمای ساختمان براساس مقررات ملی ساختمان مقایسه گردید. …”
    Get full text
    Article
  18. 7078
  19. 7079

    Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer by Maria Ignez Freitas Melro Braghiroli, Daniel Santos Rocha Sobral Filho, Juliana Goes Martins Fagundes, Elizabeth Zambrano Mendoza, Maria Fernanda Batistuzzo Vicentini Neffa, Karla Souza Campos, Leonardo Gomes da Fonseca, Renata Colombo Bonadio, Aley Talans, Oddone Freitas Melro Braghiroli, Maria Cecília Mathias-Machado, Jorge Sabbaga, Camila Motta Venchiarutti Moniz, Paulo Marcelo Gehm Hoff

    Published 2024-01-01
    “…There was no significant difference in median overall survival between treatment groups (9.1 months [I + C] vs 10.1 months [I + P]; p = 0.76). There was also no difference in progression-free survival (3.63 months [I + C] vs 3.73 months [I + P]; p = 0.19) and objective response rate (23.0 % [I + C] vs 22.3 % [I + P]; p = 0.97). …”
    Get full text
    Article
  20. 7080

    Penerapan Importance Performance Analysis (IPA) pada Evaluasi Keberlanjutan Penggunaan e-filing untuk Pelaporan Pajak Perorangan by Imelda Saluza, Dewi Sartika

    Published 2022-02-01
    “…This is conducted to enhance customer experience. To get the most out of e-filing as a method of uploading individual tax returns (SPT). …”
    Get full text
    Article